4.7 Review

Pilus of Streptococcus pneumoniae: structure, function and vaccine potential

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Carriers and Antigens: New Developments in Glycoconjugate Vaccines

Robert M. F. van der Put et al.

Summary: Glycoconjugate vaccines have shown their value in preventing infectious diseases, with the Haemophilus influenzae type b vaccine being the best example. These vaccines consist of carrier proteins and carbohydrate antigens. Current carrier proteins include tetanus toxoid, diphtheria toxoid, CRM197, Haemophilus protein D, and the outer membrane protein complex of serogroup B meningococcus. Carbohydrate antigens are mainly produced by extraction and purification, but recent advancements have been made in the synthesis of oligosaccharides and bioconjugation.

VACCINES (2023)

Article Infectious Diseases

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator- controlled, multicentre, US-based trial

Heather Platt et al.

Summary: This study evaluated an investigational 21-valent pneumococcal conjugate vaccine (V116) specifically targeting serotypes associated with residual disease burden in adults. The results showed that V116 had a similar safety and immunogenicity profile compared to PPSV23, and was superior to PPSV23 for nine unique serotypes. These findings support the use of V116 for prevention of pneumococcal disease in adults.

LANCET INFECTIOUS DISEASES (2023)

Review Immunology

Emerging vaccine strategies against the incessant pneumococcal disease

Jeremy A. Duke et al.

Summary: The incidence of invasive pneumococcal disease (IPD) caused by infection with Streptococcus pneumoniae has been decreasing due to vaccination programs. However, the global burden of S. pneumoniae is still significant, emphasizing the need for new vaccination strategies. This review focuses on immune mechanisms triggered by existing pneumococcal vaccines and discusses challenges faced in selecting serotypes and using pneumococcal-derived proteins as vaccine antigens.

NPJ VACCINES (2023)

Article Biochemistry & Molecular Biology

New structural insights into the PI-2 pilus from Streptococcus oralis, an early dental plaque colonizer

Rajnesh Kumari Yadav et al.

Summary: Streptococcus oralis, a member of the mitis group of oral streptococci, plays a significant role in periodontal disease, dental caries, and other oral infections. It promotes biofilm growth by coaggregating with other early colonizers such as Actinomyces oris. This study investigates the role of the PI-2 pilus in the mutualistic mechanism between S. oralis and A. oris, and suggests the potential use of galactose monosaccharide as a ligand to inhibit coaggregation and control oral biofilm development.

FEBS JOURNAL (2022)

Article Multidisciplinary Sciences

Membrane particles evoke a serotype-independent cross-protection against pneumococcal infection that is dependent on the conserved lipoproteins MalX and PrsA

Ana Rita Narciso et al.

Summary: Intranasal immunization with pneumococcal membrane particles (MPs) provides excellent serotype-independent protection against invasive pneumococcal disease (IPD). The conserved lipoproteins MalX and PrsA are identified as the main antigens responsible for cross-protection. Omitting variable surface proteins and vaccine candidate PspA enhances protective immune responses to the conserved proteins.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Review Immunology

Chitosan-Based Nanomaterial as Immune Adjuvant and Delivery Carrier for Vaccines

Xiaochen Gong et al.

Summary: This article introduces the application of chitosan in vaccine adjuvants and drug delivery systems. Chitosan has good biocompatibility and low toxicity, and can effectively enhance immune responses. Chitosan-based nanoparticles serve as excellent delivery systems and play important roles in protein vaccines and nucleic acid vaccines.

VACCINES (2022)

Article Infectious Diseases

Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study

Stephanie W. Lo et al.

Summary: The study found that the increase in the 24F serotype globally is mainly due to the clonal spread of three lineages, with GPSC10 (CC230) being the only multidrug-resistant lineage driving the increase in France. Spatial-temporal analysis revealed that it took 3-5 years for GPSC10-24F to spread across France, and a rapid change in serotype composition was observed in neighboring countries during the introduction of PCV13.

LANCET MICROBE (2022)

Article Immunology

Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23)

Jeff Fairman et al.

Summary: This study successfully developed a 24-valent PCV using a proprietary cell-free protein synthesis platform, which showed promising immunogenicity with conjugate-like immune responses to all 24 serotypes. The novel technology has the potential to improve serotype coverage compared to traditional PCVs.

VACCINE (2021)

Review Biochemistry & Molecular Biology

The impact of the ancillary pilus-1 protein RrgA of Streptococcus pneumoniae on colonization and disease

Federico Iovino et al.

MOLECULAR MICROBIOLOGY (2020)

Review Microbiology

Pilus islets and the clonal spread of piliated Streptococcus pneumoniae: A review

Nurul Diana Dzaraly et al.

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2020)

Review Biotechnology & Applied Microbiology

Development of pneumococcal vaccines over the last 10 years

Nicola Principi et al.

EXPERT OPINION ON BIOLOGICAL THERAPY (2018)

Article Immunology

Receptor Blockade: A Novel Approach to Protect the Brain From Pneumococcal Invasion

Federico Iovino et al.

JOURNAL OF INFECTIOUS DISEASES (2018)

Article Immunology

pIgR and PEC AM-1 bind to pneumococcal adhesins RrgA and PspC mediating bacterial brain invasion

Federico Iovino et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Microbiology

Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update

Arif Tasleem Jan

FRONTIERS IN MICROBIOLOGY (2017)

Review Microbiology

A visual review of the human pathogen Streptococcus pneumoniae

Ditte Hoyer Engholm et al.

FEMS MICROBIOLOGY REVIEWS (2017)

Review Chemistry, Medicinal

Pneumonia and Streptococcus pneumoniae vaccine

Gyu-Lee Kim et al.

ARCHIVES OF PHARMACAL RESEARCH (2017)

Article Medicine, Research & Experimental

Pneumococcal meningitis is promoted by single cocci expressing pilus adhesin RrgA

Federico Iovino et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Review Biochemistry & Molecular Biology

How Does Streptococcus pneumoniae Invade the Brain?

Federico Iovino et al.

TRENDS IN MICROBIOLOGY (2016)

Article Immunology

Vaccine escape of piliated Streptococcus pneumoniae strains

Gili Regev-Yochay et al.

VACCINE (2016)

Review Biochemical Research Methods

Streptococcus pneumoniae proteomics: determinants of pathogenesis and vaccine development

Mustapha Bittaye et al.

EXPERT REVIEW OF PROTEOMICS (2015)

Article Biochemistry & Molecular Biology

A Structural Snapshot of Type II Pilus Formation in Streptococcus pneumoniae

Md Munan Shaik et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Review Microbiology

Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus

Mark J. Walker et al.

CLINICAL MICROBIOLOGY REVIEWS (2014)

Article Biochemistry & Molecular Biology

Structural Basis of Pilus Anchoring by the Ancillary Pilin RrgC of Streptococcus pneumoniae

Md Munan Shaik et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Review Infectious Diseases

Review: Current and new generation pneumococcal vaccines

Charles Feldman et al.

JOURNAL OF INFECTION (2014)

Review Immunology

Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Immunogenicity

Maria Deloria Knoll et al.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2014)

Review Chemistry, Medicinal

Novel Strategies for Development of Next-Generation Glycoconjugate Vaccines

Fikri Y. Avci

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

Toll-like Receptor (TLR) 2 Mediates Inflammatory Responses to Oligomerized RrgA Pneumococcal Pilus Type 1 Protein

Alan Basset et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Letter Medicine, General & Internal

Global, regional, and national causes of child mortality

Bernadette Modell et al.

LANCET (2012)

Article Biochemistry & Molecular Biology

Structural and Functional Characterization of the Streptococcus pneumoniae RrgB Pilus Backbone D1 Domain

Maria Antonietta Gentile et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Structural Basis of Host Cell Recognition by the Pilus Adhesin from Streptococcus pneumoniae

Thierry Izore et al.

STRUCTURE (2010)

Article Infectious Diseases

Prevalence of pilus encoding islets among acute otitis mediaStreptococcus pneumoniaeisolates from Israel.

Monica Moschioni et al.

CLINICAL MICROBIOLOGY AND INFECTION (2009)

Article Biochemistry & Molecular Biology

Molecular architecture of Streptococcus pneumoniae TIGR4 pili

Markus Hilleringmann et al.

EMBO JOURNAL (2009)

Article Immunology

Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related

Monica Moschioni et al.

JOURNAL OF INFECTIOUS DISEASES (2008)

Article Biochemistry & Molecular Biology

Sortase-mediated assembly and surface topology of adhesive pneumococcal pili

Stefan Falker et al.

MOLECULAR MICROBIOLOGY (2008)

Article Microbiology

Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg A

Markus Hilleringmann et al.

PLOS PATHOGENS (2008)

Article Biochemistry & Molecular Biology

RrgA is a pilus-associated adhesin in Streptococcus pneumoniae

A. L. Nelson et al.

MOLECULAR MICROBIOLOGY (2007)

Article Immunology

Streptococcus pneumoniae pilus subunits protect mice against lethal challenge

Claudia Gianfaldoni et al.

INFECTION AND IMMUNITY (2007)

Article Multidisciplinary Sciences

A pneumococcal pilus influences virulence and host inflammatory responses

MA Barocchi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Multidisciplinary Sciences

Group A Streptococcus produce pilus-like structures containing protective antigens and Lancefield T antigens

M Mora et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Medicine, General & Internal

WHO estimates of the causes of death in children

J Bryce et al.

LANCET (2005)

Article Microbiology

Construction of new unencapsulated (rough) strains of Streptococcus pneumoniae

BJ Pearce et al.

RESEARCH IN MICROBIOLOGY (2002)